ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
다우존스 지수
43,487.83
0.78%
Bitcoin
103,598.38
-0.51%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Astrazeneca Plc (AZN) 시세

Astrazeneca Plc

Astrazeneca Plc (AZN)

AstraZeneca PLC
AZN Capital Corp
10,938.00
94.00
(0.87%)
마감 18 1월 1:30AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
10,938.00
매수가
10,932.00
매도가
10,934.00
거래량
2,773,047
10,910.00 일간 변동폭 11,122.00
9,461.00 52주 범위 13,338.00
market_cap
169.574B
전일 종가
10,844.00
개장가
10,950.00
최근 거래 시간
3
@
10936
(O)
마지막 거래 시간
재정 규모
304,183,373p
VWAP
10,969.283
평균 볼륨(3m)
2,772,974
발행 주식
1,550,317,189
배당수익률
2.14%
주가수익률
28.46
주당순이익(EPS)
3.84
매출
45.81B
순이익
5.96B

Astrazeneca Plc 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
본부
Cambridge, Gbr
설립됨
-
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the 런던증권거래소 with ticker AZN. The last closing price for Astrazeneca was 10,844p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 13,338.00p.

Astrazeneca currently has 1,550,317,189 shares in issue. The market capitalisation of Astrazeneca is £168.12 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 28.46.

AZN 최신 뉴스

추가 뉴스

AstraZeneca's Calquence gets US approval for mantle cell lymphoma

AstraZeneca PLC on Friday said its drug Calquence, in combination with chemoimmunotherapy, has received approval from ...

21 시간 전
Alliance News

AstraZeneca PLC Calquence combination approved in US for 1L MCL

AstraZeneca PLC 17 January 2025   17 January 2025   Calquence plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma   Based on ECHO Phase III...

22 시간 전
RNS Regulatory News

AstraZeneca and Daiichi Sankyo cheer priority US review of cancer drug

AstraZeneca PLC on Monday said its lung cancer treatment, co-developed with Daiichi Sankyo Co Ltd, is under priority ...

13 1월 2025
Alliance News

AstraZeneca breast cancer drug Lynparza given green light for NHS use

Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light f ...

09 1월 2025
Alliance News

AstraZeneca PLC Total Voting Rights

AstraZeneca PLC 02 January 2025   2 January 2025     Transparency Directive Voting rights and capital   The following notification is made in accordance with the UK Financial Conduct...

03 1월 2025
RNS Regulatory News

AstraZeneca and Daiichi withdraw EU application for lung cancer drug

AstraZeneca PLC and its Japanese partner Daiichi-Sankyo Co Ltd have withdrawn an application in the European Union fo ...

24 12월 2024
Alliance News
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-42-0.382513661202109801112210578272349110784.0910869DE
47167.00450009783102221112210084221080310655.2758301DE
12-752-6.4328485885411690117169670277297410432.4429765DE
26-1162-9.6033057851212100133389670225865511270.0768454DE
524384.1714285714310500133389461229509111168.1904421DE
156235827.48251748258580133388214219964610757.5628385DE
260319941.3360899341773913338587122831729591.46283672DE

AZN - Frequently Asked Questions (FAQ)

What is the current Astrazeneca share price?
The current share price of Astrazeneca is 10,938.00p
How many Astrazeneca shares are in issue?
Astrazeneca has 1,550,317,189 shares in issue
What is the market cap of Astrazeneca?
The market capitalisation of Astrazeneca is GBP 168.12B
What is the 1 year trading range for Astrazeneca share price?
Astrazeneca has traded in the range of 9,461.00p to 13,338.00p during the past year
What is the PE ratio of Astrazeneca?
The price to earnings ratio of Astrazeneca is 28.46
What is the cash to sales ratio of Astrazeneca?
The cash to sales ratio of Astrazeneca is 3.7
What is the reporting currency for Astrazeneca?
Astrazeneca reports financial results in USD
What is the latest annual turnover for Astrazeneca?
The latest annual turnover of Astrazeneca is USD 45.81B
What is the latest annual profit for Astrazeneca?
The latest annual profit of Astrazeneca is USD 5.96B
What is the registered address of Astrazeneca?
The registered address for Astrazeneca is 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA
Which industry sector does Astrazeneca operate in?
Astrazeneca operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
QBTQuantum Blockchain Technologies Plc
1.625p
(124.14%)
460.21M
PPSProton Motor Power Systems Plc
0.425p
(112.50%)
3.73M
IMMImmupharma Plc
3.60p
(37.14%)
9.73M
MIRIMirriad Advertising Plc
0.20p
(25.00%)
51M
BMVBluebird Mining Ventures Ltd
0.75p
(25.00%)
30.39M
IGRIg Design Group Plc
59.00p
(-58.60%)
9.76M
CELCeladon Pharmaceuticals Plc
22.00p
(-31.25%)
1.23M
DGI9Digital 9 Infrastructure Plc
14.90p
(-25.87%)
14.49M
PREMPremier African Minerals Limited
0.0275p
(-23.61%)
2.06B
NOGNostrum Oil & Gas Plc
2.60p
(-20.12%)
30.22k
PREMPremier African Minerals Limited
0.0275p
(-23.61%)
2.06B
NTVONativo Resources Plc
0.0019p
(0.00%)
1.06B
TRPTower Resources Plc
0.031p
(-4.62%)
750.67M
SYMESupply@me Capital Plc
0.0039p
(16.42%)
550.3M
QBTQuantum Blockchain Technologies Plc
1.625p
(124.14%)
460.21M

토론

전체 피드 보기
Drugdoctor Drugdoctor 32 초 전
Remember, assets from other stock mergers will be added to $FORW's holding company. Right now, something is happening with American Blockchain, our CEO's other shell, and if it is the first to merger, some assets will be coming here. Can't wait for $FORW's chart to look like this.

h
FORW
MONTANAJOE MONTANAJOE 42 초 전
Like it better when they just talk to each other and leave everyone else alone!!
NBRI
TucsonPhil TucsonPhil 42 초 전
Wow. According to OTC markets, the OS count is now 5,988,649,454. Last time I checked was last year, and I recall it was around 3.9B, when the AS was 5B, then they raised the AS to 10B and have been busy with quite a bit of dilution.
KGKG
MONTANAJOE MONTANAJOE 42 초 전
Like it better when they just talk to each other and leave everyone else alone!!
NBRI
againstallodds againstallodds 3 분 전
https://investorshub.advfn.com/uimage/uploads/2025/1/17/rarvyIMG_0265.jpeg

0.5 oz of rhodium per ton of ore can be considered a very high-grade deposit. Here's why:
* Rhodium is extremely rare: It's one of the rarest and most valuable precious metals.
* Typical grades
NBRI
EarningsCentral EarningsCentral 5 분 전
TLRY
Drugdoctor Drugdoctor 7 분 전
Who made 300% gains-with-George-Sharp's-$GVSI??>>

https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
GVSI
axelvento axelvento 7 분 전
Moderna is preparing to advance mRNA-1018 into Phase 3. The Company looks forward to sharing the Phase 1/2 results at an upcoming scientific meeting.
MRNA
gitreal gitreal 8 분 전
Could it be Mt Vernon assays are flawed, and that the extraordibary Rhodiun assays are skewed ?

Skewed? No.
Made up? Yes.
NBRI
Drugdoctor Drugdoctor 8 분 전
Check the accumulation line on chart>>>

https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
GVSI
sylvia07 sylvia07 8 분 전
Where are the BASHERS when good news is announced, always missing?
GRST
dinogreeves dinogreeves 9 분 전
Only time will tell which direction they take. In either case, let's get the FID first and hopefully merger not too long after. This is ripe for massive move, with the latest on the media and the Senators in the mix, now imagine that with the merger news and Motley Fool article a long while back w
TGLO
againstallodds againstallodds 10 분 전
Why no mining at Mt Vernon???

Closer to the mill than Fran
NBRI
gitreal gitreal 10 분 전
You're so clever.
AABB
georgie18 georgie18 11 분 전
Your very welcome…🥳
KULR
RobotDroid RobotDroid 11 분 전
Won't hold up next week as the lack of news from mute inept nonmanagement will continue as January falls to February.
NWBO
georgie18 georgie18 12 분 전
Nope…🥳
UMAV
dinogreeves dinogreeves 12 분 전
Also true.
TGLO
dinogreeves dinogreeves 14 분 전
Chen on my previous post I explained the scenario with NUK*K. Number one reason it ran the way it did was the publicity it had with Iron Dome for Israel, second it ran because of the demand it had for a low float, third and most important and must remember, no options, stocks that have no options a
TGLO
NorthPeak22 NorthPeak22 15 분 전
I personally think they will be separate actions. The merger news will be about a private company merging with a shell company on the OTC. The potential RS would coincide with an uplisting announcement once the SEC gives approval for all of it.
TGLO
NorthPeak22 NorthPeak22 19 분 전
There's a ton more institutions that won't be buying into private placements and will be buying on the open market. Delfin will be financed by the big boys, the smaller ones will fight it out with the rest of us.
TGLO
shajandr shajandr 19 분 전
Buckey, if I recall your background story correctly (low probability of that), you turned down a hockey scholly at a hockey-strong U in the USA and instead went the route of the minors to the NHL. Is my recollection correct? If so, which U(s) offered you a hockey scholly?

TIA.
Hardazoak Hardazoak 19 분 전
I have noticed that the more paragraphs you write of your lies, means you are more desperate. I have checked your messages from 2021 just before it exploded above 60 cents,same long lies . No way to hide it. This means aabb price about to explode. Can't wait.
AABB
Moonboy1 Moonboy1 20 분 전
Wow look at this POS tank. Will be funny if trump signs an executive order next week to legalize federally. Any thing is possible. The stock is so low now it's a great opportunity for congressional insider trading
ACB
NorthPeak22 NorthPeak22 21 분 전
I looked back at the TELL chart, starting in August 2016 (merger announcement) they ran from $.50 all the way up to $21.74 by March 2017(merger finalized). Then it dumped hard. That's also when Cherif Souki used his TELL shares as collateral for the giant real estate loan that did him in. I don't th
TGLO

최근 히스토리

LSE
AZN
Astrazeneca
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유